查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
切片機的全球市場:各產品(設備，(旋轉式)，配件(切片機刀片))，用途(疾病診斷，醫學研究)，技術(全自動，半自動，手動)，終端用戶(醫院，臨床實驗室) - 至2027年的預測
市場調查報告書
商品編碼
1075378

切片機的全球市場:各產品(設備，(旋轉式)，配件(切片機刀片))，用途(疾病診斷，醫學研究)，技術(全自動，半自動，手動)，終端用戶(醫院，臨床實驗室) - 至2027年的預測

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 211 Pages | 訂單完成後即時交付

價格
簡介目錄

全球切片機市場成長，在醫院實驗室進行的特殊的診斷檢驗數增加，醫院內的臨床診斷程序增加，全球醫院數增加，醫院內的臨床診斷能力的確立傾向增加等成為主要原因。

本報告提供全球切片機市場的相關調查，市場動態，價格，專利，貿易的分析，生態系統，各市場區隔、地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 課題
    • 市場機會
  • COVID-19對切片機市場的影響
  • 範圍/情境
  • 價值鏈分析
  • 供應鏈分析
  • 科技分析
  • 波特的五力分析
  • 主要的利害關係者與購買標準
  • 法規情形
  • 專利分析
  • 2022年主要的會議和活動
  • 價格分析
  • 貿易分析
  • 生態系統分析
  • 影響客戶業務的趨勢/阻礙

第6章 各產品:切片機市場

  • 切片機設備
    • 旋轉式
    • 低溫恆溫器
    • 震動
    • 其他
  • 切片機配件
    • 切片機刀片
    • 其他

第7章 各技術:切片機市場

  • 手動切片機
  • 半自動切片機
  • 全自動切片機

第8章 各用途:切片機市場

  • 疾病診斷
  • 醫學研究

第9章 各終端用戶:切片機市場

  • 醫院實驗室
  • 臨床實驗室
  • 其他

第10章 各地區:切片機市場

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區

第11章 競爭情形

  • 概要
  • 主要企業的策略/成功機會
  • 市場佔有率分析
  • 企業的評估矩陣
  • 中小企業/Start-Ups的企業評估矩陣
  • 企業的足跡分析
  • 競爭基準
  • 競爭模式

第12章 企業簡介

  • 主要企業
    • DANAHER CORPORATION
    • PHC HOLDINGS CORPORATION
    • CARDINAL HEALTH
    • BOECKELER INSTRUMENTS, INC.
    • BRIGHT INSTRUMENTS LTD.
    • ERMA INC.
    • HISTO-LINE LABORATORIES
    • JINHUA YIDI MEDICAL APPLIANCE CO., LTD.
    • MEDIMEAS
    • MEDITE MEDICAL GMBH
    • MICROTEC LABORGERATE GMBH
    • SAKURA FINETEK USA, INC.
    • SLEE MEDICAL GMBH
    • SM SCIENTIFIC INSTRUMENTS PVT. LTD.
    • TED PELLA, INC.
  • 其他企業
    • AGD BIOMEDICALS PVT. LTD.
    • AMOS SCIENTIFIC PTY LTD.
    • CAMPDEN INSTRUMENTS LTD.
    • DIAPATH S.P.A.
    • LABOID INTERNATIONAL
    • LAFAYETTE INSTRUMENT COMPANY
    • LUPETEC
    • MILESTONE MEDICAL
    • RWD LIFE SCIENCE CO., LTD.
    • SHENZHEN DAKEWEI BIOTECHNOLOGY CO., LTD.

第13章 附錄

簡介目錄
Product Code: MD 7308

Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals.

"Microtome instruments in the product segment to witness the highest shares during the forecast period."

Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

In this report, the microtome market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising disposable income of the middle-class population, infrastructural developments, and the rising penetration of diagnostic technologies in Asian countries such as India and China in addition, the rising incidence of cancer and the growing focus of global medical device companies on expanding their presence in emerging Asia Pacific countries are some of the key factors.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
  • By Designation: C-level (30%), Director-level (34%), and Others (36%)
  • By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)

List of Companies Profiled in the Report

  • Danaher Corporation (US)
  • Boeckeler Instruments, Inc (US)
  • SM Scientific Instruments Pvt. Ltd. (India)
  • PHC holdings corporation (Japan)
  • Cardinal Health (US)
  • Bright Instruments (UK)
  • Sakura Finetek USA, Inc (US)
  • Jinhua Yidi Medical Equipment Co., Ltd (China)
  • Ted Pella, Inc (US)
  • Medimeas (India)
  • SLEE medical GmbH (Germany)
  • Histo-Line Laboratories (Italy)
  • microTec Laborgerate GmbH (Germany)
  • MEDITE Medical GmbH (Germany)
  • Campden Instruments. (UK)
  • Lupetec (Brazil)
  • AGD BIOMEDICALS PVT LTD (India)
  • Lafayette Instrument Company (US)
  • MILESTONE MEDICAL (US)
  • Diapath S.p.A. (Italy)
  • RWD Life Science Co., LTD (China)
  • LABOID INTERNATIONAL (India)
  • Shenzhen Dakewei Biotechnology Co., Ltd. (China)
  • Amos scientific Pty Ltd (Australia)
  • Campden Instruments. (UK)

Research Coverage:

This report studies the microtome market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total microtome market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on microtome products offered by the top 25 players in the microtome market. The report analyzes the microtome market by product, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the microtme market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the microtome market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 YEARS COVERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: DANAHER CORPORATION
    • FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.1 GROWTH FORECAST
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 8 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
    • 2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

    • FIGURE 10 MICROTOMES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 MICROTOMES MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 MICROTOMES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 MICROTOMES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 GLOBAL MICROTOMES MARKET: GEOGRAPHIC SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 MICROTOMES MARKET OVERVIEW
    • FIGURE 15 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
  • 4.2 MICROTOMES MARKET, BY PRODUCT
    • FIGURE 16 FULLY AUTOMATED MICROTOMES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • 4.3 ASIA PACIFIC: MICROTOMES MARKET, BY PRODUCT AND COUNTRY
    • FIGURE 17 ROTARY MICROTOMES SEGMENT WILL DOMINATE APAC MARKET DURING FORECAST PERIOD
  • 4.4 GEOGRAPHIC SNAPSHOT OF MICROTOMES MARKET
    • FIGURE 18 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 MICROTOMES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of cancer
    • TABLE 2 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 3 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035
      • 5.2.1.2 Growing demand for digital pathology
      • 5.2.1.3 Recommendations for cancer screening
      • 5.2.1.4 Availability of reimbursement
    • 5.2.2 CHALLENGES
      • 5.2.2.1 Lack of skilled professionals
    • TABLE 4 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
      • 5.2.2.2 Availability of refurbished products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing focus on personalized medicine
      • 5.2.3.2 Emerging economies
  • 5.3 IMPACT OF COVID-19 ON MICROTOMES MARKET
  • 5.4 RANGES/SCENARIOS
    • 5.4.1 MICROTOMES MARKET
    • FIGURE 20 PESSIMISTIC SCENARIO
    • FIGURE 21 OPTIMISTIC SCENARIO
    • FIGURE 22 REALISTIC SCENARIO
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.7 TECHNOLOGY ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 THREAT OF SUBSTITUTES
  • 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 2 END USERS
    • TABLE 5 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 2 END USERS
    • 5.9.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR TOP 2 END USERS
    • TABLE 6 KEY BUYING CRITERIA FOR TOP 2 END USERS
  • 5.10 REGULATORY LANDSCAPE
    • TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MICROTOMES MARKET
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY CONFERENCES & EVENTS IN 2022
    • TABLE 8 LIST OF CONFERENCES & EVENTS
  • 5.13 PRICING ANALYSIS
    • TABLE 9 PRICE RANGE FOR MICROTOMES
  • 5.14 TRADE ANALYSIS
    • TABLE 10 IMPORT DATA FOR MICROTOMES AND PARTS AND ACCESSORIES OF INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 11 EXPORT DATA FOR MICROTOMES AND PARTS AND ACCESSORIES OF INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.15 ECOSYSTEM ANALYSIS
    • 5.15.1 ROLE IN ECOSYSTEM
    • 5.15.2 KEY PLAYERS OPERATING IN MICROTOMES MARKET
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES

6 MICROTOMES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 12 MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 13 MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
  • 6.2 MICROTOME INSTRUMENTS
    • TABLE 14 MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 15 MICROTOME INSTRUMENTS MARKET, BY TYPE, 2021-2027 (USD MILLION)
    • TABLE 16 MICROTOME INSTRUMENTS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 17 MICROTOME INSTRUMENTS MARKET, BY REGION, 2021-2027 (USD MILLION)
    • 6.2.1 ROTARY MICROTOMES
      • 6.2.1.1 Rotary microtomes are widely used in histology laboratories
    • TABLE 18 ROTARY MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 19 ROTARY MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 20 ROTARY MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)
    • 6.2.2 CRYOSTAT MICROTOMES
      • 6.2.2.1 Cryostat microtomes provide immediate results by quickly, reliably, and safely cutting accurate frozen sections
    • TABLE 21 CRYOSTAT MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 22 CRYOSTAT MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 23 CRYOSTAT MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)
    • 6.2.3 VIBRATING MICROTOMES
      • 6.2.3.1 Vibrating microtomes are designed to cut fresh tissue specimens
    • TABLE 24 VIBRATING MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 25 VIBRATING MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 26 VIBRATING MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)
    • 6.2.4 OTHER MICROTOMES
    • TABLE 27 OTHER MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 28 OTHER MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 29 OTHER MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)
  • 6.3 MICROTOME ACCESSORIES
    • TABLE 30 MICROTOME ACCESSORIES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 31 MICROTOME ACCESSORIES MARKET, BY TYPE, 2021-2027 (USD MILLION)
    • 6.3.1 MICROTOME BLADES
      • 6.3.1.1 Adoption of disposable blades has increased among end users
    • TABLE 32 MICROTOME BLADES OFFERED BY MARKET PLAYERS
    • TABLE 33 MICROTOME BLADES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 34 MICROTOME BLADES MARKET, BY REGION, 2021-2027 (USD MILLION)
    • 6.3.2 OTHER MICROTOME ACCESSORIES
    • TABLE 35 OTHER MICROTOME ACCESSORIES OFFERED BY MARKET PLAYERS
    • TABLE 36 OTHER MICROTOME ACCESSORIES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 37 OTHER MICROTOME ACCESSORIES MARKET, BY REGION, 2021-2027 (USD MILLION)

7 MICROTOMES MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 38 MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 39 MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
  • 7.2 MANUAL MICROTOMES
    • 7.2.1 LOWER COST AND USER COMFORT ASSOCIATED WITH THESE MICROTOMES ARE DRIVING THEIR ADOPTION
    • TABLE 40 MANUAL MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 41 MANUAL MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 42 MANUAL MICROTOMES MARKET, BY REGION, 2021-2027 USD MILLION)
  • 7.3 SEMI-AUTOMATED MICROTOMES
    • 7.3.1 SEMI-AUTOMATED MICROTOMES SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    • TABLE 43 SEMI-AUTOMATED MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 44 SEMI-AUTOMATED MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 45 SEMI-AUTOMATED MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)
  • 7.4 FULLY AUTOMATED MICROTOMES
    • 7.4.1 LACK OF CLINICAL LABORATORY TECHNICIANS AND HIGH PREVALENCE OF CANCER HAVE DRIVEN SEGMENT GROWTH
    • TABLE 46 FULLY AUTOMATED MICROTOMES OFFERED BY MARKET PLAYERS
    • TABLE 47 FULLY AUTOMATED MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 48 FULLY AUTOMATED MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)

8 MICROTOMES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 49 MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 50 MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
  • 8.2 DISEASE DIAGNOSIS
    • 8.2.1 EXPANDING POOL OF GERIATRIC PATIENTS AND INCREASING DIAGNOSIS OF CHRONIC DISEASES DRIVING SEGMENT GROWTH
    • TABLE 51 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 52 MICROTOMES MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 53 MICROTOMES MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2021-2027 (USD MILLION)
  • 8.3 MEDICAL RESEARCH
    • 8.3.1 INCREASING RESEARCH ACTIVITIES TO DRIVE ADOPTION OF MICROTOMES
    • TABLE 54 MICROTOMES MARKET FOR MEDICAL RESEARCH, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 55 MICROTOMES MARKET FOR MEDICAL RESEARCH, BY REGION, 2021-2027 (USD MILLION)

9 MICROTOMES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 56 MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 57 MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 9.2 HOSPITAL LABORATORIES
    • 9.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    • TABLE 58 MICROTOMES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 59 MICROTOMES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2021-2027 (USD MILLION)
  • 9.3 CLINICAL LABORATORIES
    • 9.3.1 PRESENCE OF ROBUST INFRASTRUCTURE TO PERFORM TESTS IN HIGH VOLUMES IS ESTIMATED TO DRIVE MARKET GROWTH
    • TABLE 60 MICROTOMES MARKET FOR CLINICAL LABORATORIES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 61 MICROTOMES MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021-2027 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 62 MICROTOMES MARKET FOR OTHER END USERS, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 63 MICROTOMES MARKET FOR OTHER END USERS, BY REGION, 2021-2027 (USD MILLION)

10 MICROTOMES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 64 MICROTOMES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 65 MICROTOMES MARKET, BY REGION, 2021-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012-2035
    • FIGURE 28 NORTH AMERICA: MICROTOMES MARKET SNAPSHOT
    • TABLE 66 NORTH AMERICA: MICROTOMES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 67 NORTH AMERICA: MICROTOMES MARKET, BY COUNTRY, 2021-2027 (USD MILLION)
    • TABLE 68 NORTH AMERICA: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 69 NORTH AMERICA: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 70 NORTH AMERICA: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 71 NORTH AMERICA: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2021-2027 (USD MILLION)
    • TABLE 72 NORTH AMERICA: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 73 NORTH AMERICA: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 75 NORTH AMERICA: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 76 NORTH AMERICA: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 77 NORTH AMERICA: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 High burden of cancer and numerous conferences on anatomic pathology to drive market growth
    • TABLE 78 US: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 79 US: KEY MACROINDICATORS
    • TABLE 80 US: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 81 US: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 82 US: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 83 US: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 84 US: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 85 US: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 86 US: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 87 US: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Availability of research funding and rising incidence of cancer to drive market growth
    • TABLE 88 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 89 CANADA: KEY MACROINDICATORS
    • TABLE 90 CANADA: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 91 CANADA: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 92 CANADA: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 93 CANADA: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 94 CANADA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 95 CANADA: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 96 CANADA: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 97 CANADA: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 10.3 EUROPE
    • FIGURE 29 EUROPE: CANCER INCIDENCE & MORTALITY, 2012-2035
    • TABLE 98 EUROPE: MICROTOMES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 99 EUROPE: MICROTOMES MARKET, BY COUNTRY, 2021-2027 (USD MILLION)
    • TABLE 100 EUROPE: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 101 EUROPE: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 102 EUROPE: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 103 EUROPE: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2021-2027 (USD MILLION)
    • TABLE 104 EUROPE: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 105 EUROPE: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 106 EUROPE: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 107 EUROPE: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 108 EUROPE: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 109 EUROPE: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing prevalence of chronic diseases to drive market growth
    • TABLE 110 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 111 GERMANY: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 112 GERMANY: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 113 GERMANY: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 114 GERMANY: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 115 GERMANY: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 116 GERMANY: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 117 GERMANY: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 118 GERMANY: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 High prevalence of cancer to support market growth in France
    • TABLE 119 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 120 FRANCE: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 121 FRANCE: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 122 FRANCE: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 123 FRANCE: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 124 FRANCE: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 125 FRANCE: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 126 FRANCE: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 127 FRANCE: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Favorable government initiatives to drive market growth
    • TABLE 128 UK: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 129 UK: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 130 UK: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 131 UK: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 132 UK: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 133 UK: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 134 UK: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 135 UK: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 High prevalence of cancer and increasing per capita healthcare spending to support market growth in Italy
    • TABLE 136 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 137 ITALY: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 138 ITALY: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 139 ITALY: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 140 ITALY: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 141 ITALY: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 142 ITALY: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 143 ITALY: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 144 ITALY: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 High incidence of chronic diseases to drive market growth in Spain
    • TABLE 145 SPAIN: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 146 SPAIN: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 147 SPAIN: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 148 SPAIN: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 149 SPAIN: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 150 SPAIN: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 151 SPAIN: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 152 SPAIN: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 153 SPAIN: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 154 LUNG CANCER INCIDENCE IN KEY ROE COUNTRIES, 2020 VS. 2040
    • TABLE 155 LIVER CANCER INCIDENCE IN KEY ROE COUNTRIES, 2020 VS. 2040
    • TABLE 156 ROE: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 157 ROE: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 158 ROE: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 159 ROE: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 160 ROE: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 161 ROE: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 162 ROE: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 163 ROE: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: CANCER INCIDENCE & MORTALITY, 2012-2035
    • FIGURE 31 ASIA PACIFIC: MICROTOMES MARKET SNAPSHOT
    • TABLE 164 ASIA PACIFIC: MICROTOMES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: MICROTOMES MARKET, BY COUNTRY, 2021-2027 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 167 ASIA PACIFIC: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2021-2027 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 171 ASIA PACIFIC: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 172 ASIA PACIFIC: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 173 ASIA PACIFIC: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 174 ASIA PACIFIC: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 175 ASIA PACIFIC: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Presence of well-developed healthcare system to support market growth in Japan
    • TABLE 176 JAPAN: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 177 JAPAN: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 178 JAPAN: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 179 JAPAN: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 180 JAPAN: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 181 JAPAN: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 182 JAPAN: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 183 JAPAN: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 184 JAPAN: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Rising healthcare expenditure to drive market growth in China
    • TABLE 185 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 186 CHINA: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 187 CHINA: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 188 CHINA: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 189 CHINA: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 190 CHINA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 191 CHINA: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 192 CHINA: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 193 CHINA: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing healthcare sector to drive market growth in India
    • TABLE 194 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 195 INDIA: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 196 INDIA: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 197 INDIA: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 198 INDIA: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 199 INDIA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 200 INDIA: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 201 INDIA: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 202 INDIA: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 203 ROAPAC: INCIDENCE OF CANCER, BY COUNTRY, 2020 VS. 2040
    • TABLE 204 ROAPAC: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 205 ROAPAC: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 206 ROAPAC: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 207 ROAPAC: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 208 ROAPAC: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 209 ROAPAC: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 210 ROAPAC: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 211 ROAPAC: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 212 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 213 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 214 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 215 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 216 ROW: MICROTOMES MARKET, BY PRODUCT, 2017-2020 (USD MILLION)
    • TABLE 217 ROW: MICROTOMES MARKET, BY PRODUCT, 2021-2027 (USD MILLION)
    • TABLE 218 ROW: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 219 ROW: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2021-2027 (USD MILLION)
    • TABLE 220 ROW: MICROTOMES MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
    • TABLE 221 ROW: MICROTOMES MARKET, BY APPLICATION, 2021-2027 (USD MILLION)
    • TABLE 222 ROW: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2020 (USD MILLION)
    • TABLE 223 ROW: MICROTOMES MARKET, BY TECHNOLOGY, 2021-2027 (USD MILLION)
    • TABLE 224 ROW: MICROTOMES MARKET, BY END USER, 2017-2020 (USD MILLION)
    • TABLE 225 ROW: MICROTOMES MARKET, BY END USER, 2021-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 226 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 MARKET SHARE ANALYSIS
    • TABLE 227 MICROTOMES MARKET: DEGREE OF COMPETITION
  • 11.4 COMPANY EVALUATION MATRIX
    • 11.4.1 STARS
    • 11.4.2 EMERGING LEADERS
    • 11.4.3 PERVASIVE PLAYERS
    • 11.4.4 PARTICIPANTS
    • FIGURE 32 COMPANY EVALUATION MATRIX: MICROTOMES MARKET
  • 11.5 COMPANY EVALUATION MATRIX FOR SMES/START-UPS
    • 11.5.1 PROGRESSIVE COMPANIES
    • 11.5.2 STARTING BLOCKS
    • 11.5.3 RESPONSIVE COMPANIES
    • 11.5.4 DYNAMIC COMPANIES
    • FIGURE 33 COMPANY EVALUATION MATRIX FOR SMES/START-UPS: MICROTOMES MARKET
  • 11.6 COMPANY FOOTPRINT ANALYSIS
    • TABLE 228 OVERALL FOOTPRINT OF COMPANIES
    • TABLE 229 REGIONAL FOOTPRINT OF COMPANIES
    • TABLE 230 PRODUCT FOOTPRINT OF COMPANIES
  • 11.7 COMPETITIVE BENCHMARKING
    • TABLE 231 MICROTOMES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT LAUNCHES
    • TABLE 232 KEY PRODUCT LAUNCHES
    • 11.8.2 DEALS
    • TABLE 233 KEY DEALS
    • 11.8.3 OTHER DEVELOPMENTS
    • TABLE 234 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 DANAHER CORPORATION
    • TABLE 235 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.2 PHC HOLDINGS CORPORATION
    • TABLE 236 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 35 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.3 CARDINAL HEALTH
    • TABLE 237 CARDINAL HEALTH: BUSINESS OVERVIEW
    • FIGURE 36 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
    • 12.1.4 BOECKELER INSTRUMENTS, INC.
    • TABLE 238 BOECKELER INSTRUMENTS, INC.: BUSINESS OVERVIEW
    • 12.1.5 BRIGHT INSTRUMENTS LTD.
    • TABLE 239 BRIGHT INSTRUMENTS LTD.: BUSINESS OVERVIEW
    • 12.1.6 ERMA INC.
    • TABLE 240 ERMA INC.: BUSINESS OVERVIEW
    • 12.1.7 HISTO-LINE LABORATORIES
    • TABLE 241 HISTO-LINE LABORATORIES: BUSINESS OVERVIEW
    • 12.1.8 JINHUA YIDI MEDICAL APPLIANCE CO., LTD.
    • TABLE 242 JINHUA YIDI MEDICAL APPLIANCE CO., LTD.: BUSINESS OVERVIEW
    • 12.1.9 MEDIMEAS
    • TABLE 243 MEDIMEAS: BUSINESS OVERVIEW
    • 12.1.10 MEDITE MEDICAL GMBH
    • TABLE 244 MEDITE MEDICAL GMBH: BUSINESS OVERVIEW
    • 12.1.11 MICROTEC LABORGERATE GMBH
    • TABLE 245 MICROTEC LABORGERATE GMBH: BUSINESS OVERVIEW
    • 12.1.12 SAKURA FINETEK USA, INC.
    • TABLE 246 SAKURA FINETEK USA, INC.: BUSINESS OVERVIEW
    • 12.1.13 SLEE MEDICAL GMBH
    • TABLE 247 SLEE MEDICAL GMBH: BUSINESS OVERVIEW
    • 12.1.14 SM SCIENTIFIC INSTRUMENTS PVT. LTD.
    • TABLE 248 SM SCIENTIFIC INSTRUMENTS PVT. LTD.: BUSINESS OVERVIEW
    • 12.1.15 TED PELLA, INC.
    • TABLE 249 TED PELLA, INC.: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 AGD BIOMEDICALS PVT. LTD.
    • TABLE 250 AGD BIOMEDICALS PVT. LTD.: BUSINESS OVERVIEW
    • 12.2.2 AMOS SCIENTIFIC PTY LTD.
    • TABLE 251 AMOS SCIENTIFIC PTY LTD.: BUSINESS OVERVIEW
    • 12.2.3 CAMPDEN INSTRUMENTS LTD.
    • TABLE 252 CAMPDEN INSTRUMENTS LTD.: BUSINESS OVERVIEW
    • 12.2.4 DIAPATH S.P.A.
    • TABLE 253 DIAPATH S.P.A.: BUSINESS OVERVIEW
    • 12.2.5 LABOID INTERNATIONAL
    • TABLE 254 LABOID INTERNATIONAL: BUSINESS OVERVIEW
    • 12.2.6 LAFAYETTE INSTRUMENT COMPANY
    • TABLE 255 LAFAYETTE INSTRUMENT COMPANY: BUSINESS OVERVIEW
    • 12.2.7 LUPETEC
    • TABLE 256 LUPETEC: BUSINESS OVERVIEW
    • 12.2.8 MILESTONE MEDICAL
    • TABLE 257 MILESTONE MEDICAL: BUSINESS OVERVIEW
    • 12.2.9 RWD LIFE SCIENCE CO., LTD.
    • TABLE 258 RWD LIFE SCIENCE CO., LTD.: BUSINESS OVERVIEW
    • 12.2.10 SHENZHEN DAKEWEI BIOTECHNOLOGY CO., LTD.
    • TABLE 259 SHENZHEN DAKEWEI BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS